Clinical Trial Update: A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update reports safety and preliminary efficacy data for oral midostaurin (PKC412) in relapsed or refractory pediatric leukemia, inclu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• Midostaurin (midostaurin)
• PKC412

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2015-12-22